MedTrace Logo

Respiratory Virus Outpatient Study (FLU 002 Plus)

NCT01056354 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11719

Last updated 2017-08-18

No results posted yet for this study

Summary

Following the sudden and unexpected emergence of influenza A(H1N1)pdm09 (2009 H1N1) virus, this observational study was initiated to describe participants seeking medical care in geographically diverse locations with 2009 H1N1 infection and their clinical course over a 14-day period following enrollment. In 2011, as surveillance indicated that 2009 H1N1 virus was co-circulating with other seasonal influenza A and B viruses worldwide, the protocol was expanded to include other influenza A subtypes and influenza B viruses. This version of the protocol further broadens the scope of this observational study. With the recognition that novel respiratory viruses other than novel influenza A viruses, e.g., Middle East Respiratory Syndrome Coronavirus (MERS-CoV), could become prevalent and of major public health importance, the objectives of this protocol have been expanded

Conditions

  • Influenza and Other Novel Respiratory Viruses

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Minnesota

    lead OTHER

Principal Investigators

  • James Neaton, Professor · University of Minnesota - Dept Biostatistics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2017-05-12
Completion
2017-05-12

Countries

  • United States
  • Argentina
  • Australia
  • Belgium
  • Chile
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Japan
  • Peru
  • Poland
  • Spain
  • Thailand
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01056354 on ClinicalTrials.gov